Goldman Sachs’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.9M Buy
4,342,755
+1,639,178
+61% +$9.39M ﹤0.01% 1626
2025
Q1
$22.1M Buy
2,703,577
+194,213
+8% +$1.58M ﹤0.01% 1632
2024
Q4
$23.6M Sell
2,509,364
-680,926
-21% -$6.41M ﹤0.01% 1648
2024
Q3
$34.1M Buy
3,190,290
+1,707,931
+115% +$18.2M 0.01% 1332
2024
Q2
$14.7M Buy
1,482,359
+140,469
+10% +$1.39M ﹤0.01% 1798
2024
Q1
$15.8M Sell
1,341,890
-780,855
-37% -$9.2M ﹤0.01% 1700
2023
Q4
$30.1M Sell
2,122,745
-395,339
-16% -$5.61M 0.01% 1282
2023
Q3
$30.6M Sell
2,518,084
-278,037
-10% -$3.38M 0.01% 1206
2023
Q2
$35.1M Buy
2,796,121
+885,390
+46% +$11.1M 0.01% 1159
2023
Q1
$21.2M Buy
1,910,731
+28,103
+1% +$312K ﹤0.01% 1487
2022
Q4
$23M Sell
1,882,628
-132,668
-7% -$1.62M 0.01% 1499
2022
Q3
$21M Buy
2,015,296
+642,826
+47% +$6.71M 0.01% 1556
2022
Q2
$14.7M Sell
1,372,470
-465,365
-25% -$5M ﹤0.01% 1831
2022
Q1
$17.4M Buy
1,837,835
+500,985
+37% +$4.74M ﹤0.01% 1808
2021
Q4
$15.4M Sell
1,336,850
-790,905
-37% -$9.14M ﹤0.01% 1946
2021
Q3
$20.3M Buy
2,127,755
+124,543
+6% +$1.19M ﹤0.01% 1722
2021
Q2
$19.3M Sell
2,003,212
-61,340
-3% -$591K ﹤0.01% 1759
2021
Q1
$20.4M Sell
2,064,552
-888,354
-30% -$8.78M 0.01% 1671
2020
Q4
$68.2M Buy
2,952,906
+415,368
+16% +$9.59M 0.02% 750
2020
Q3
$35.8M Sell
2,537,538
-145,551
-5% -$2.06M 0.01% 1082
2020
Q2
$40.5M Sell
2,683,089
-648,098
-19% -$9.77M 0.01% 1003
2020
Q1
$30.8M Sell
3,331,187
-41,765
-1% -$386K 0.01% 1081
2019
Q4
$32.9M Buy
3,372,952
+1,007,617
+43% +$9.81M 0.01% 1292
2019
Q3
$19M Buy
2,365,335
+8,938
+0.4% +$71.7K 0.01% 1557
2019
Q2
$29.4M Sell
2,356,397
-94,185
-4% -$1.18M 0.01% 1351
2019
Q1
$33.3M Buy
2,450,582
+732,392
+43% +$9.96M 0.01% 1275
2018
Q4
$16.5M Buy
1,718,190
+100,526
+6% +$963K 0.01% 1648
2018
Q3
$19.6M Buy
1,617,664
+524,887
+48% +$6.35M 0.01% 1666
2018
Q2
$17.1M Sell
1,092,777
-268,664
-20% -$4.2M ﹤0.01% 1723
2018
Q1
$20.5M Sell
1,361,441
-201,591
-13% -$3.03M 0.01% 1561
2017
Q4
$22.5M Buy
1,563,032
+385,182
+33% +$5.54M 0.01% 1498
2017
Q3
$17.8M Buy
1,177,850
+255,944
+28% +$3.86M ﹤0.01% 1659
2017
Q2
$9.28M Buy
921,906
+144,760
+19% +$1.46M ﹤0.01% 1965
2017
Q1
$5.54M Buy
777,146
+41,711
+6% +$297K ﹤0.01% 2143
2016
Q4
$3.66M Buy
735,435
+360,666
+96% +$1.79M ﹤0.01% 2366
2016
Q3
$2.77M Buy
374,769
+182,682
+95% +$1.35M ﹤0.01% 2539
2016
Q2
$1.05M Sell
192,087
-874,947
-82% -$4.78M ﹤0.01% 2917
2016
Q1
$9.02M Sell
1,067,034
-332,760
-24% -$2.81M ﹤0.01% 1784
2015
Q4
$13.6M Buy
1,399,794
+194,680
+16% +$1.89M ﹤0.01% 1525
2015
Q3
$16.9M Buy
1,205,114
+6,965
+0.6% +$97.4K 0.01% 1363
2015
Q2
$17M Sell
1,198,149
-303,284
-20% -$4.29M 0.01% 1427
2015
Q1
$16.3M Buy
1,501,433
+376,463
+33% +$4.1M 0.01% 1405
2014
Q4
$9.36M Buy
1,124,970
+1,037,048
+1,180% +$8.63M ﹤0.01% 1639
2014
Q3
$523K Buy
87,922
+25,182
+40% +$150K ﹤0.01% 3299
2014
Q2
$210K Buy
62,740
+18,692
+42% +$62.6K ﹤0.01% 3947
2014
Q1
$91K Sell
44,048
-8,476
-16% -$17.5K ﹤0.01% 4154
2013
Q4
$123K Sell
52,524
-19,778
-27% -$46.3K ﹤0.01% 4037
2013
Q3
$168K Sell
72,302
-2,046
-3% -$4.75K ﹤0.01% 3898
2013
Q2
$173K Buy
+74,348
New +$173K ﹤0.01% 3679